Archive for the ‘Diseases Multiple Sclerosis’ Category
Multiple Sclerosis Health Tips
June 27th, 2010 | 
Author: When the term Multiple Sclerosis is said we often as quick to think about a slow as debilitating degradation of a person into a state that they are not able to live on their own. The truth is that this does not always have to be the case. There are things that a person can do to make their existence better and slow the rate of bodily control loss that they experience. With these tips you can easily extend the time that you can enjoy a high quality of living, even with MS.
Dealing With Disease – Multiple Sclerosis Health Tips
When the term Multiple Sclerosis is said we often as quick to think about a slow as debilitating degradation of a person into a state that they are not able to live on their own. The truth is that this does not always have to be the case. There are things that a person can do to make their existence better and slow the rate of bodily control loss that they experience. With these tips you can easily extend the time that you can enjoy a high quality of living, even with MS.
Understanding Multiple Sclerosis and Parkinsons Disease
Children and adults with debilitating diseases like multiple sclerosis (MS), Parkinson’s and Lou Gehrig’s disease (amyotrophic lateral sclerosis or ALS) undergo a gradual reduction in their body’s ability to perform voluntary muscular functions. They are slow diseases without cures. Today’s treatment generally consists of medications and techniques to slow down the symptoms of the disease and the degeneration of the body. Scientists are not quite sure what causes these diseases; though there are cases that show that a small number of sufferers may inherit them.
Multiple sclerosis is a disease that causes the immune system of your body to consume the protective covering over your nerves. This leads to irreversible nerve damage. The degree and impact of the disease relies on which nerves are affected. The disease can develop at any age, but generally strikes those between 20 and 40 and women over men. Though the effects are fleeting in the beginning, those with MS will experience a gradual deterioration. A positive attitude is just as important to the treatment of the disease as any medical therapies.
Multiple Sclerosis – What to Expect and is There a Cure?
Multiple sclerosis is not an uncommon disease. Although genetic makeup has a hand in causing it, geographical location and environmental conditions may affect the onset of the disease as well. Studies show that more Caucasians are suffering from the said disease and the risk of having it is higher for those that are living in the North of the equator. The disease affects the central nervous system and results to loss of insulation around the nerves. It can affect various areas of the body and worse, may lead to paralysis.
The disease is not fatal in itself, but complications may be life threatening. The disease causes immobility and can lead to unfortunate accidents. About 2.5 million people all over the world suffer from this disease, and this includes young people, with more women being affected.
Could Early Symptoms of MS Be Stratified to Give Better Targeted Multiple Sclerosis Treatments? Introduction
Multiple sclerosis presents in various ways and subsequently shows variable disease courses. If we knew early on what the disease course for Multiple Sclerosis would be then we could better target the medication in each individual case. To date it has been unpredictable right from disease onset but, knowing the disease course is of crucial importance in guiding treatment.
Now “The Department of Neurosciences” at Cardiff University has recently been looking into factor H as a biomarker for multiple sclerosis and the findings are promising.
Effective and accessible biomarkers are needed in order to stratify (separate into groups) patients and inform treatment. The team at Cardiff University decided to look into factor H as such a marker. Regulator factor H, has recently been implicated as a biomarker in other chronic inflammatory central nervous system conditions. Could it identify or predict specific pathological processes and outcomes in multiple sclerosis?